CHR Stock Overview
Chr. Hansen Holding A/S, a bioscience company, develops natural ingredient solutions for the food, nutritional, pharmaceutical, and agricultural industries in Europe, the Middle East, Africa, North America, Latin America, and the Asia Pacific.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Chr. Hansen Holding A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr.551.40 |
| 52 Week High | kr.604.00 |
| 52 Week Low | kr.417.70 |
| Beta | 0.33 |
| 1 Month Change | 5.07% |
| 3 Month Change | 17.27% |
| 1 Year Change | 24.08% |
| 3 Year Change | -8.95% |
| 5 Year Change | -7.51% |
| Change since IPO | 480.42% |
Recent News & Updates
Recent updates
Chr. Hansen Holding (CPH:CHR) Will Be Hoping To Turn Its Returns On Capital Around
Jun 26
These 4 Measures Indicate That Chr. Hansen Holding (CPH:CHR) Is Using Debt Reasonably Well
May 21Chr. Hansen Holding (CPH:CHR) Could Be Struggling To Allocate Capital
Mar 28Chr. Hansen Holding's (CPH:CHR) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 14Chr. Hansen Holding (CPH:CHR) Is Paying Out A Larger Dividend Than Last Year
Oct 29Chr. Hansen Holding (CPH:CHR) Is Increasing Its Dividend To €7.04
Oct 15Here's What's Concerning About Chr. Hansen Holding's (CPH:CHR) Returns On Capital
Sep 13These 4 Measures Indicate That Chr. Hansen Holding (CPH:CHR) Is Using Debt Reasonably Well
Aug 29A Look At The Intrinsic Value Of Chr. Hansen Holding A/S (CPH:CHR)
Aug 13Capital Allocation Trends At Chr. Hansen Holding (CPH:CHR) Aren't Ideal
Jun 12Chr. Hansen Holding (CPH:CHR) Seems To Use Debt Quite Sensibly
May 24A Look At The Fair Value Of Chr. Hansen Holding A/S (CPH:CHR)
May 09There Are Reasons To Feel Uneasy About Chr. Hansen Holding's (CPH:CHR) Returns On Capital
Mar 06Does Chr. Hansen Holding (CPH:CHR) Have A Healthy Balance Sheet?
Feb 19Estimating The Fair Value Of Chr. Hansen Holding A/S (CPH:CHR)
Feb 03Chr. Hansen Holding (CPH:CHR) Will Want To Turn Around Its Return Trends
Dec 01These 4 Measures Indicate That Chr. Hansen Holding (CPH:CHR) Is Using Debt Reasonably Well
Nov 09Are Chr. Hansen Holding A/S (CPH:CHR) Investors Paying Above The Intrinsic Value?
Oct 26Chr. Hansen Holding (CPH:CHR) Could Be Struggling To Allocate Capital
Aug 19Does Chr. Hansen Holding (CPH:CHR) Have A Healthy Balance Sheet?
Aug 02Chr. Hansen Holding's (CPH:CHR) Soft Earnings Are Actually Better Than They Appear
Jul 15Chr. Hansen Holding (CPH:CHR) Could Be Struggling To Allocate Capital
May 17We Think Chr. Hansen Holding (CPH:CHR) Can Stay On Top Of Its Debt
Apr 29Do Institutions Own Chr. Hansen Holding A/S (CPH:CHR) Shares?
Mar 17Chr. Hansen Holding (CPH:CHR) Shareholders Have Enjoyed A 36% Share Price Gain
Feb 15Our Take On The Returns On Capital At Chr. Hansen Holding (CPH:CHR)
Feb 01
Chr. Hansen Holding (CPH:CHR) Seems To Use Debt Quite Sensibly
Jan 16Is Chr. Hansen Holding A/S (CPH:CHR) A High Quality Stock To Own?
Jan 01What Is The Ownership Structure Like For Chr. Hansen Holding A/S (CPH:CHR)?
Dec 16How Does Chr. Hansen Holding's (CPH:CHR) CEO Salary Compare to Peers?
Dec 02Shareholder Returns
| CHR | DK Chemicals | DK Market | |
|---|---|---|---|
| 7D | 0.7% | 1.6% | -2.1% |
| 1Y | 24.1% | 2.8% | 16.8% |
Return vs Industry: CHR exceeded the Danish Chemicals industry which returned 1.7% over the past year.
Return vs Market: CHR exceeded the Danish Market which returned 18.4% over the past year.
Price Volatility
| CHR volatility | |
|---|---|
| CHR Average Weekly Movement | 3.7% |
| Chemicals Industry Average Movement | 4.7% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DK Market | 9.5% |
| 10% least volatile stocks in DK Market | 2.7% |
Stable Share Price: CHR is not significantly more volatile than the rest of Danish stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: CHR's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1843 | 3,834 | Mauricio Graber | https://www.chr-hansen.com |
Chr. Hansen Holding A/S, a bioscience company, develops natural ingredient solutions for the food, nutritional, pharmaceutical, and agricultural industries in Europe, the Middle East, Africa, North America, Latin America, and the Asia Pacific. The company operates through Food Cultures & Enzymes, and Health & Nutrition segments. The Food Cultures & Enzymes segment produces and sells various cultures, enzymes, and probiotic products that determine the taste, flavor, texture, shelf life, nutritional value, and health benefits of various consumer products in the food industry, primarily in the dairy industry.
Chr. Hansen Holding A/S Fundamentals Summary
| CHR fundamental statistics | |
|---|---|
| Market Cap | kr.72.57b |
| Earnings (TTM) | kr.1.69b |
| Revenue (TTM) | kr.9.95b |
42.9x
P/E Ratio7.3x
P/S RatioIs CHR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CHR income statement (TTM) | |
|---|---|
| Revenue | €1.33b |
| Cost of Revenue | €611.10m |
| Gross Profit | €723.30m |
| Other Expenses | €496.30m |
| Earnings | €227.00m |
Last Reported Earnings
Aug 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.72 |
| Gross Margin | 54.20% |
| Net Profit Margin | 17.01% |
| Debt/Equity Ratio | 52.0% |
How did CHR perform over the long term?
See historical performance and comparison